Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

NCT00861744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1259

Enrollment

INDUSTRY

Sponsor class

Conditions

Rubella
Mumps
Measles
Measles-Mumps-Rubella Vaccine

Interventions

BIOLOGICAL: GSK Biological's investigational vaccine 209762
BIOLOGICAL: M-M-R® II (Merck and Co)
BIOLOGICAL: Varivax®
BIOLOGICAL: Havrix®
BIOLOGICAL: Prevnar®

Sponsor

GlaxoSmithKline